Shopping Cart

Your shopping cart is currently empty

Ro24-7429

Name: Ro24-7429
Brand: TargetMol
SKU: T28578
Price: 84 USD
Availability: InStock
Rating: 5 (10 reviews)

(Synonyms: Ro-24-7429, Ro 24-7429, Ro 247429) Copy Product Info

🥰Excellent

Synonyms: Ro-24-7429, Ro 24-7429, Ro 247429

Catalog No. T28578 Copy Product Info

Purity: 99.85%

🥰Excellent

Ro24-7429 is a small molecule inhibitor, an HIV-1 Tat antagonist and RUNX1 inhibitor, with oral activity, cell permeability, and anti-inflammatory effects, used for anti-HIV, anti-fibrotic, and inflammation-related research.

Cas No. 139339-45-0

Customer service consultation

Pack Size	Price	USA Stock	Global Stock
1 mg	$84	In Stock	In Stock
5 mg	$197	In Stock	In Stock
10 mg	$313	In Stock	In Stock
25 mg	$533	In Stock	In Stock
50 mg	$768	In Stock	In Stock
100 mg	$1,080	In Stock	In Stock
500 mg	$3,028	6-8 weeks	6-8 weeks
1 mL x 10 mM (in DMSO)	$226	In Stock	In Stock

For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)

Add to Cart

Add to Quotation

For research use only—not for human use. No sales to individuals. Use as intended only.

Questions

Batch Information

Select Batch

Purity:99.85%

Appearance:Solid

Color:White to Yellow

Resource Download

COA LCMS HNMR

Product Introduction

Bioactivity

Description	Ro24-7429 is a small molecule inhibitor, an HIV-1 Tat antagonist and RUNX1 inhibitor, with oral activity, cell permeability, and anti-inflammatory effects, used for anti-HIV, anti-fibrotic, and inflammation-related research.
Targets & IC50	C8166 cells:0.7 μM
In vitro	Methods: Cultured PBMCs or lymphocytes were treated with Ro 24-7429 (0.1-25 μM) to detect apoptosis and antigen-induced lymphocyte proliferation. Results: Ro 24-7429 induced PBMC apoptosis in a dose-dependent manner and inhibited antigen-induced lymphocyte proliferation.[1] Methods: A549 and HLF cells were treated with Ro24-7429 (50-200 μM) for 24-72 hours to detect cell proliferation and TNF-α-induced RUNX1 mRNA expression. Results: Ro24-7429 potently inhibited cell proliferation in a dose-dependent manner, and significantly reduced TNF-α-induced RUNX1 mRNA upregulation by 50% at 75 μM after 48-hour treatment.[2]
In vivo	Methods: In a bleomycin-induced pulmonary fibrosis mouse model, Ro24-7429 (17.5-70 mg/kg; once daily) was administered via intraperitoneal injection for 14 or 21 days to evaluate its effects on pulmonary fibrosis and inflammation. Results: Ro24-7429 significantly ameliorated pulmonary fibrosis and inflammation, and inhibited the expression of fibrotic markers in the lungs of injured mice. [2]
Synonyms	Ro-24-7429, Ro 24-7429, Ro 247429

Chemical Properties

Molecular Weight	272.73
Formula	C₁₄H₁₃ClN₄
Cas No.	139339-45-0
Smiles	CNC1=Nc2ccc(Cl)cc2C(=NC1)c1ccc[nH]1
Relative Density.	1.36g/cm3

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 140 mg/mL (513.33 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (14.67 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	3.6666 mL	18.3332 mL	36.6663 mL	183.3315 mL
5 mM	0.7333 mL	3.6666 mL	7.3333 mL	36.6663 mL
10 mM	0.3667 mL	1.8333 mL	3.6666 mL	18.3332 mL
20 mM	0.1833 mL	0.9167 mL	1.8333 mL	9.1666 mL
50 mM	0.0733 mL	0.3667 mL	0.7333 mL	3.6666 mL
100 mM	0.0367 mL	0.1833 mL	0.3667 mL	1.8333 mL

Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 µL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc